Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP003386) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
Fab Rivabazumab
|
|||||
| Synonyms |
TAB-472CQ
|
|||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Highest Status | Phase II | |||||
| SBP Sequence |
>VH Chain
EVQLVESGGGVVQPGRSLRLSCAASGFTFSNYPMHWVRQAPGKGLEWVAVISYDGSEKWY ADSVKGRFTISRDNSKNTLYLEMNSLRPEDTAVYYCARNRGDIYYDFTYAMDIWGQGTTV TVSS >VL Chain DIQLTQSPSTLSASVGDSVTITCRASEGVDRWLAWYQQKPGRAPKLLIYDASTLQSGVPS RFSGSGSGTEFSLTISSLQPDDVATYYCQHFWGTPYTFGQGTKLEIK |
|||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS034 | [1] | ||||
| Scaffold Name | Fab | |||||
| Scaffold Class | Antibody fragment | |||||
| Fold Type | Beta-Sheets + Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| Type III secretion protein PcrV | Binder | Research tool | N.A. | World Health Organization | [1] | |